Comparative Effectiveness of Medicated Γ-Iud (intrauterine Device) with Other IUDs for Contraception: A Systematic Review
KANG Yu-kun,WANG Li,WANG Xuan,TAN Shi-qiao,TAO Kai-yu,GAN Chang-ping,HE Ling,HUANG Li-sa,LI You-ping
DOI: https://doi.org/10.3969/j.issn.1672-2531.2006.01.009
2006-01-01
Abstract:Objective To evaluate the effectiveness of Medicated γ-IUD compared with other IUDs for contraception. Methods CBMdisc (19862005), VIP (19892005), CNKI (19942005), The Cochrane Library (Issue 4, 2005) and 10 related journals were searched for randomized controlled trials (RCTs) and quasi-randomized controlled trials (quasi-RCTs) on the comparison between γ-IUD and other IUDs. The quality of included trials was critically appraised. RevMan 4.2.8 software was used for statistical analysis. Results Ten published studies with 8 381 participants were included. The results of meta-analysis were expressed with Peto OR (cumulative pregnancy rate, cumulative expulsion rate, cumulative rate of removing for medical reasons) or OR (cumulative continuation rate) and 95% CI. Compared with MSSR-165, Medicated γ-25,200 resulted in lower pregnancy rate at 1, 2, 3 years of follow-up [with the OR (95% CI) 0.31 (0.15,0.64), 0.31 (0.17,0.54), 0.31 (0.19,0.51), respectively], lower cumulative expulsion rate in 5 year follow-up [0.26 (0.17,0.40), 0.28 (0.20,0.41), 0.30 (0.21,0.42), 0.29 (0.19,0.44), 0.32 (0.21,0.48), respectively], lower cumulative rate of removing for medical reasons after 4 year follow-up [0.57 (0.36,0.92)], and higher rate of cumulative continuation in 5 years of follow-up [3.35 (2.29,4.89), 2.76 (2.06,3.69), 2.41 (1.89,3.08), 2.22 (1.69,2.91), 1.99 (1.55,2.55), respectively]. Compared with TCu220, Medicated γ-25,200 resulted in lower cumulative pregnancy rate after follow-up 2, 3 years [0.46 (0.25,0.87); 0.48 (0.27,0.85)], lower cumulative expulsion rate after 1 year follow-up [0.58 (0.35,0.97)], lower cumulative rate of being removed for medical reasons in 5 year follow-up [0.37 (0.23,0.59), 0.38 (0.26,0.56), 0.45 (0.32,0.64), 0.47 (0.30,0.73), 0.58 (0.39,0.87), respectively] and higher rate of cumulative continuation in 5 years of follow-up [2.15 (1.61,2.87), 2.02 (1.56,2.63), 1.72 (1.34,2.20), 1.44 (1.08,1.91), 1.39 (1.07,1.80), respectively]. Compared with Uterus-Cu, Medicated γ-25,200 resulted in higher rate of cumulative continuation after follow-up 1 year [0.51 (0.34,0.77)]. Compared with MLCu375, Medicated γ-25,200 resulted in lower cumulative rate of being removed for medical reasons and higher rate of cumulative continuation after follow-up for 3 years [0.22 (0.09,0.52), 2.84 (1.64,4.94)]. Compared with TCu380A, Medicated γ-25, 200 resulted in lower cumulative rate of being removed for medical reasons and higher rate of cumulative continuation in follow-up for 2 years [0.36 (0.18,0.73), 0.29 (0.12,0.70); 3.06 (1.72,5.44), 3.61 (1.75,7.47)]. Conclusions Available evidence shows that Medicated γ-IUD has better or equal effectiveness when compared with other IUDs. However, more RCTs with high quality and longer follow-up period are needed to confirm the conclusion.